Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
pasireotide (signifor) (1 trial)
Breast Neoplasms (Phase 2)
Lymphocele (Phase 2)
Trials (1 total)
Trial APIs (1 total)